BE736215A - - Google Patents

Info

Publication number
BE736215A
BE736215A BE736215DA BE736215A BE 736215 A BE736215 A BE 736215A BE 736215D A BE736215D A BE 736215DA BE 736215 A BE736215 A BE 736215A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE736215A publication Critical patent/BE736215A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • C07D239/82Oxygen atoms with an aryl radical attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE736215D 1968-07-18 1969-07-17 BE736215A (enrdf_load_html_response)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5098368 1968-07-18
JP5098268 1968-07-18
JP7637768 1968-10-18

Publications (1)

Publication Number Publication Date
BE736215A true BE736215A (enrdf_load_html_response) 1969-12-31

Family

ID=27294150

Family Applications (1)

Application Number Title Priority Date Filing Date
BE736215D BE736215A (enrdf_load_html_response) 1968-07-18 1969-07-17

Country Status (6)

Country Link
BE (1) BE736215A (enrdf_load_html_response)
CH (2) CH527201A (enrdf_load_html_response)
DE (1) DE1935404C3 (enrdf_load_html_response)
FR (1) FR2013172B1 (enrdf_load_html_response)
GB (1) GB1251600A (enrdf_load_html_response)
NL (1) NL142957B (enrdf_load_html_response)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA986932A (en) * 1970-08-27 1976-04-06 Shigeho Inaba Process for preparing quinazoline derivatives
DE2162327C3 (de) * 1970-12-23 1975-09-18 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
JPS4918887A (enrdf_load_html_response) * 1972-02-28 1974-02-19
JPS521036A (en) 1975-06-23 1977-01-06 Sumitomo Chem Co Ltd Antiphlogistic with extremely low reaction to digestive canals
AR038658A1 (es) 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento

Also Published As

Publication number Publication date
CH515912A (de) 1971-11-30
FR2013172A1 (enrdf_load_html_response) 1970-03-27
DE1935404C3 (de) 1975-02-13
DE1935404A1 (de) 1970-01-22
DE1935404B2 (de) 1974-06-20
GB1251600A (enrdf_load_html_response) 1971-10-27
NL6910984A (enrdf_load_html_response) 1970-01-20
CH527201A (de) 1972-08-31
FR2013172B1 (enrdf_load_html_response) 1973-01-12
NL142957B (nl) 1974-08-15

Similar Documents

Publication Publication Date Title
AU428130B2 (enrdf_load_html_response)
AU2374870A (enrdf_load_html_response)
AU5184069A (enrdf_load_html_response)
AU6168869A (enrdf_load_html_response)
AU6171569A (enrdf_load_html_response)
AU429879B2 (enrdf_load_html_response)
AU416157B2 (enrdf_load_html_response)
AU2581067A (enrdf_load_html_response)
AU4811568A (enrdf_load_html_response)
AU421558B1 (enrdf_load_html_response)
AU3789668A (enrdf_load_html_response)
AU4744468A (enrdf_load_html_response)
AU3224368A (enrdf_load_html_response)
AR203075Q (enrdf_load_html_response)
AU479393A (enrdf_load_html_response)
BE708888A (enrdf_load_html_response)
AU4503667A (enrdf_load_html_response)
AU4558658A (enrdf_load_html_response)
AU463027A (enrdf_load_html_response)
AU4270368A (enrdf_load_html_response)
BE727949A (enrdf_load_html_response)
AU479894A (enrdf_load_html_response)
AU4224469A (enrdf_load_html_response)
AU3083868A (enrdf_load_html_response)
BE727866A (enrdf_load_html_response)